Meghan Stacey

A healthy dose of creativity always works

8

1 Comment

💉🧠🚪⌚ TIL more about #veintoveintime, #braintoveintime, and #veintodoortime -- all ways that drugs like CAR-Ts are being measured as efficient as well as effective. #ASH2024 saw presentations on data for "Fast CARs" with 7 day vein to vein times vs some commercial CAR-Ts with 44d V2Vt. Then I learned (and loved) about Brain to Vein time which begins "when the oncologist and the patient agree that CAR T-cell therapy is the preferred next treatment option." (Clinical Advances in Hematology & Oncology Volume 20, Issue 3 March 2022) Poster presented this weekend explored the relationship between patient race and ethnicity and brain-to-vein time in non-white and Hispanic patients with R/R DLBCL -- and found a longer B2Vt for these patients independent of insurance status. https://lnkd.in/eu8tBR8W

3

Rare disease hits too close to home– for too many. As healthcare marketers, we feel it's crucial to connect with patients on their own terms. Let's aim to empower patients and foster a supportive rare disease community. https://okt.to/q8cRCj #patientengagement #healthcaremarketing #rarediseasesupport #psp #healthcarestrategies

1

Here's an article that dives a little deeper into the DPE takeaway focused on patient adherence and prescription abandonment. IPG Health SOLVE(D) | An IPG Health Company

19

1 Comment

Hear Ipsos experts discuss the evolution of obesity treatments, including clinical efficacy and safety results, HCP and consumer perspectives, market adoption, and the access, reimbursement, and intellectual property (IP) landscapes. https://lnkd.in/gtwKas3f

1

Some added take aways of my own from this year's Publicis Health Media HealthFront: 1. Humanizing Healthcare through Storytelling: From celebrities to clients, speakers emphasized the transformative impact of storytelling in healthcare. Brian Cooley aptly put it, "Storytelling is not just a tool; in health, it is essential." 2. Navigating Digital Disruption with AI: As the healthcare landscape evolves, embracing digital disruption is essential. Many conversations centered on AI as a mechanism to amplify human capabilities and streamline workflows. Two specific statements still sit with me: Andrea Palmer challenged the room, "why not have the machine join you at the table?" And Brian Cooley highlighted the irony we are in, "we almost have to learn to be more human again to engage with the tech." 3. Prioritizing Cultural Shifts: A crucial theme underscored the importance of infusing cultural priorities into every aspect of healthcare media. Andrea Palmer reiterated, "If it's a priority to you or your patients, infuse it into your culture at every level." This was echoed by many panels throughout the day. 4. And last, my gosh it was good to see you all, former co-workers and colleagues alike. Kudos again to the events team behind it all: Lannise Galbraith, CMP, Nicole Webber, Alison McConnell, Mark Bolen, Emily Honig, Nika Chugh and so many others. #PHMHealthFront #PHMLove

12

Doctors’ Emotional Connections…to Prescription Drug Brands? As residents of a brand-saturated culture, we all know how important brands are in our lives. For example, and to be extremely specific, the Pantone green shade (PMS 3425 C) of the Starbucks logo has a positive visceral effect on me. This reaction is triggered, no doubt, by the conditioning effects of their powerfully caffeinated beverages on dopamine release in my brain over the course of a lifetime. When it comes to patients, it is easy to understand how someone could come to love a medication, based on how quickly and reliably it relieves their distressing symptoms. Conversely, many people come to hate a medication, because of the burdensome nature of the dosing, the taste of the liquid, or the unpleasant side effects. But what about doctors? Are prescription drugs simply simply tools of their trade that they view in a neutral, dispassionate manner? I think not. I maintain that doctors can have strong emotional reactions to Rx medications. When I practiced emergency medicine, there were some medications in which I had great confidence and which I enjoyed administering because of how well, how quickly, and how consistently they worked. IV adenosine for supraventricular tachycardia comes to mind. Being able to control an SVT instantly with a simple injection made me feel wonderful, powerful, almost god-like. Other medications made me uncomfortable through repeated associations with negative situations. For example, ketorolac (an injectable NSAID) was introduced with great fanfare as a potent non-opioid pain reliever. But, as soon as we started using it, patients whom we suspected of drug-seeking behavior claimed to be allergic to it. This led to a series of stressful and contentious encounters in our emergency department. And consider the challenging matter of drug compliance. How often do doctors prescribe medications while suspecting, in the back of their minds, that their patient will not take the drug as recommended because its dosing schedule is unrealistic? How does that make doctors feel? Then there are the high-priced treatments that the doctor knows, even as they prescribe the medication through the EHR, will lead to pushback from the payor based on cost or prior authorization requirements, leading to additional paperwork and treatment delays. These are just a few examples of a curious, sometimes impactful, though rarely discussed, emotional aspect of being a prescriber.

2

“I want” represents intention. “I will” represents motivation. Behavior can be a tricky thing to crack. Check out the first in a series of articles about how we leverage behavioral science to move customers from desire to doing.

14

Patient engagement just got a major upgrade. Introducing our 2025 marketing solutions built for pharma brands. At MyHealthTeam, we’ve launched these solutions to help brands authentically connect with over 27 million patients across 60+ condition-specific networks. Through trusted patient communities and medically reviewed content, we’re creating new ways to engage patients in their health journey — when it matters most. Curious about how these solutions can transform your marketing strategy? Get the details here. #PharmaMarketing #PatientEngagement #DTC #MyHealthTeam

15

1 Comment

Headed to Future Pharma? Don’t miss Acxiom's VP Sales and Strategy Anthony Passarelli on June 26 at 4 p.m. as he joins the mainstage panel discussing how data can foster a collaborative environment and improve patient outcomes. Learn how Acxiom helps pharma brands reach healthcare providers and keep them informed of products and services that can enhance patient care:

3

The clean room future is no longer on the horizon – it’s here. And for leading companies in every industry, clean rooms are transforming marketing strategies. 80% of advertisers spending over $1B on media are already using them. But here's the thing – most brands are only scratching the surface. While many are using clean rooms for audience insights, only a third are leveraging advanced measurement like attribution and ROAS. And broader collaboration across partners and complementary brands offers even greater potential. Modern clean rooms are now fully interoperable, breaking down silos between brands, retailers, and media partners. In talking with companies across industries, I constantly hear their desire to get started, but also recognize that this represents unexplored territory for many. To help companies navigate the complexity, LiveRamp has put together a playbook of some of the most common tactics, and I've attached a link here. Happy reading!

108

2 Comments

The latest issue of Unlock Health’s The LINK emphasizes the importance of keeping the conversation about inclusiontop of mind all the time. And use the healthcare awareness months to intentionally celebrate progress we’ve made, and plan for even better days ahead for all. #healthcare #marketing #consumerinsights

4

The future is coming into focus…through the perspectives of those who will lead us there.

10